CLL

>

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Latest News

fda sign.
Therapies Which Received FDA Approval in July: What Patients Should Know

July 1st 2025

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology indications and cancer types.

Linda Cohen is a survivor of small lymphocytic lymphoma and was diagnosed in 2009. Catch up on all of Linda's blogs here!
A Cocktail and the Freedom I Never Expected With Cancer

July 1st 2025

Image of blood cells.
June Blood Cancer Highlights: Top 5 Updates Patients Should Know

June 26th 2025

Breyanzi demonstrated a 95.5% response rate among in relapsed/refractory marginal zone lymphoma: © stock.adobe.com.
Breyanzi Shows Durable Responses in R/R Marginal Zone Lymphoma

June 17th 2025

FDA approves new Brukinsa tablet for five blood cancers: © stock.adobe.com.
FDA Approves Brukinsa Tablet For Various Blood Cancers

June 12th 2025

More News